Trupanion Inc (TRUP) gains 4.68% for July 21

Equities Staff  |

Trupanion Inc (NASDAQ: TRUP) shares gained 4.68%, or $5.22 per share, to close Wednesday at $116.72. After opening the day at $111.50, shares of Trupanion fluctuated between $117.00 and $111.50. 225,666 shares traded hands a decrease from their 30 day average of 299,267. Wednesday's activity brought Trupanion’s market cap to $4,675,490,741.

Trupanion is headquartered in Seattle, Washington..

About Trupanion Inc

Trupanion is a leader in medical insurance for cats and dogs throughout the United States and Canada. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet owners with the highest value in pet medical insurance with unlimited payouts for the life of their pets. Trupanion is listed on NASDAQ under the symbol 'TRUP'. The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in Canada, by Omega General Insurance Company.

Visit Trupanion Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Trupanion Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Trupanion Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content